Related Experiment Video
Updated: Apr 27, 2026

09:59
A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
16.7K
Susceptibility-diffusion mismatch predicts thrombolytic outcomes: a retrospective cohort study
1From the Departments of Neurology (M.L., Z.C., J.W., H.H., X.C., Z.S.) hzzjsjz@163.com loumingxc@vip.sina.com.
AJNR. American Journal of Neuroradiology
|July 12, 2014
Summary
Susceptibility-weighted imaging (SWI) and diffusion-weighted imaging (DWI) mismatch may identify stroke patients who benefit from thrombolytic therapy. This imaging marker indicates salvageable brain tissue, improving treatment outcomes.
Area of Science:
- Neuroimaging
- Cerebrovascular Diseases
- Medical Diagnostics
Background:
- Asymmetric hypointensity of cerebral veins on SWI suggests hypoxia post-ischemia.
- SWI-DWI mismatch may indicate salvageable brain tissue in ischemic stroke.
Purpose of the Study:
- To determine if prominent SWI-DWI mismatch predicts better outcomes with thrombolytic therapy.
- To assess the utility of SWI-DWI mismatch in identifying stroke patients who benefit from reperfusion treatments.
Main Methods:
- Retrospective analysis of ischemic stroke patients receiving thrombolysis.
- Defined SWI-DWI mismatch using asymmetry index (≥1.75) and DWI lesion volume (≤25 mL).
- Logistic regression analyzed the association between mismatch profile and favorable outcome (modified Rankin Scale 0-2 at 3 months).
Main Results:
- Patients with SWI-DWI mismatch had significantly higher favorable outcome rates (78% vs. 44%; aOR=6.317, P=.037).
- Mismatch group showed improved outcomes with reperfusion (91% vs. 43%, P=.033) and recanalization (100% vs. 40%, P=.013).
- SWI-DWI mismatch demonstrated higher accuracy (63%) than perfusion-diffusion mismatch (48.1%) in predicting favorable outcomes.
Conclusions:
- SWI-DWI mismatch is a valuable imaging biomarker for identifying ischemic stroke patients who benefit from early reperfusion therapy.
- This imaging approach can aid in selecting appropriate candidates for thrombolytic treatment.

